Zenotech [ZENOTECH] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison
Zenotech
BSE
Loading...
Sun Pharma Advanced
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Zenotech wins in 12 metrics, Sun Pharma Advanced wins in 6 metrics, with 0 ties. Zenotech appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zenotech | Sun Pharma Advanced | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 63.79 | -13.85 | Sun Pharma Advanced |
| Price-to-Book Ratio | 3.55 | -21.83 | Sun Pharma Advanced |
| Debt-to-Equity Ratio | 0.00 | -1.24 | Sun Pharma Advanced |
| PEG Ratio | -2.68 | 0.30 | Zenotech |
| EV/EBITDA | 21.21 | -17.66 | Sun Pharma Advanced |
| Profit Margin (TTM) | 13.11% | -53.22% | Zenotech |
| Operating Margin (TTM) | 13.84% | -568.05% | Zenotech |
| EBITDA Margin (TTM) | 13.84% | N/A | N/A |
| Return on Equity | 5.84% | 157.88% | Sun Pharma Advanced |
| Return on Assets (TTM) | 5.06% | -102.08% | Zenotech |
| Free Cash Flow (TTM) | $56.25M | $-3.71B | Zenotech |
| 1-Year Return | -22.09% | -35.58% | Zenotech |
| Price-to-Sales Ratio (TTM) | 8.36 | 73.39 | Zenotech |
| Enterprise Value | $3.17B | $50.08B | Sun Pharma Advanced |
| EV/Revenue Ratio | 7.81 | 77.52 | Zenotech |
| Gross Profit Margin (TTM) | 100.00% | -10.68% | Zenotech |
| Revenue per Share (TTM) | $7 | $2 | Zenotech |
| Earnings per Share (Diluted) | $0.87 | $-9.19 | Zenotech |
| Beta (Stock Volatility) | -0.09 | 0.31 | Zenotech |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zenotech vs Sun Pharma Advanced Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zenotech | -0.94% | -0.94% | -9.00% | -12.79% | 1.80% | -23.20% |
| Sun Pharma Advanced | -1.47% | -3.03% | -4.92% | -13.36% | 17.11% | -28.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zenotech | -22.09% | -4.50% | 107.21% | 66.24% | -31.53% | -55.08% |
| Sun Pharma Advanced | -35.58% | -37.00% | -18.78% | -60.87% | 53.70% | -50.94% |
Performance & Financial Health Analysis: Zenotech vs Sun Pharma Advanced
| Metric | ZENOTECH | SPARC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.39B | ₹47.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,495 | 250,949 |
| 90 Day Avg. Volume | 8,526 | 349,451 |
| Last Close | ₹54.98 | ₹142.59 |
| 52 Week Range | ₹51.00 - ₹107.79 | ₹109.30 - ₹241.00 |
| % from 52W High | -48.99% | -40.83% |
| All-Time High | ₹173.59 (Oct 01, 2007) | ₹875.00 (Apr 24, 2006) |
| % from All-Time High | -68.33% | -83.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.22% | -0.43% |
| Quarterly Earnings Growth | -0.23% | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | -0.53% |
| Operating Margin (TTM) | 0.14% | -5.68% |
| Return on Equity (TTM) | 0.06% | 1.58% |
| Debt to Equity (MRQ) | 0.00 | -1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹15.63 | ₹-6.69 |
| Cash per Share (MRQ) | ₹4.32 | ₹0.06 |
| Operating Cash Flow (TTM) | ₹69.82M | ₹-3,484,287,000 |
| Levered Free Cash Flow (TTM) | ₹56.13M | ₹-3,425,094,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Zenotech vs Sun Pharma Advanced
| Metric | ZENOTECH | SPARC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 63.79 | -13.85 |
| Forward P/E | N/A | 2.64 |
| PEG Ratio | -2.68 | 0.30 |
| Price to Sales (TTM) | 8.36 | 73.39 |
| Price to Book (MRQ) | 3.55 | -21.83 |
| Market Capitalization | ||
| Market Capitalization | ₹3.39B | ₹47.41B |
| Enterprise Value | ₹3.17B | ₹50.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.81 | 77.52 |
| Enterprise to EBITDA | 21.21 | -17.66 |
| Risk & Other Metrics | ||
| Beta | -0.09 | 0.31 |
| Book Value per Share (MRQ) | ₹15.63 | ₹-6.69 |
Financial Statements Comparison: Zenotech vs Sun Pharma Advanced
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZENOTECH | SPARC |
|---|---|---|
| Revenue/Sales | ₹86.39M | ₹96.40M |
| Cost of Goods Sold | ₹0 | ₹106.70M |
| Gross Profit | ₹86.39M | ₹-10.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹6.88M | ₹-547.60M |
| EBITDA | ₹30.51M | ₹-429.40M |
| Pre-Tax Income | ₹12.77M | ₹-518.10M |
| Income Tax | ₹2.87M | ₹600,000 |
| Net Income (Profit) | ₹9.90M | ₹-518.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZENOTECH | SPARC |
|---|---|---|
| Cash & Equivalents | ₹265.75M | ₹19.64M |
| Total Current Assets | ₹359.89M | ₹261.97M |
| Total Current Liabilities | ₹125.87M | ₹3.74B |
| Long-Term Debt | ₹0 | ₹1.07B |
| Total Shareholders Equity | ₹961.31M | ₹-2.17B |
| Retained Earnings | N/A | ₹-23.22B |
| Property, Plant & Equipment | ₹608.67M | ₹178.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZENOTECH | SPARC |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZENOTECH | SPARC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,495 | 250,949 |
| Average Daily Volume (90 Day) | 8,526 | 349,451 |
| Shares Outstanding | 61.03M | 324.52M |
| Float Shares | 12.03M | 91.74M |
| % Held by Insiders | 0.85% | 0.73% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Zenotech vs Sun Pharma Advanced
| Metric | ZENOTECH | SPARC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |